Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 16, Issue 6, Pages 501-512
Publisher
Informa UK Limited
Online
2018-05-31
DOI
10.1080/14787210.2018.1483238
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased tuberculosis risk among immigrants arriving in California with abnormal domestic chest radiographs
- (2018) J. Wong et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from disease
- (2018) Delia Goletti et al. RESPIROLOGY
- Preventive therapy for latent tuberculosis infection—the promise and the challenges
- (2017) G.J. Fox et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA
- (2017) Désirée van der Heijde et al. RHEUMATOLOGY
- Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis
- (2017) Alexander Edwards et al. THORAX
- Immunological characterization of latent tuberculosis infection in a low endemic country
- (2017) Roelof A. de Paus et al. TUBERCULOSIS
- Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis
- (2017) E. Petruccioli et al. TUBERCULOSIS
- Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials
- (2017) Zheng Zhang et al. BMJ Open
- Incidência de tuberculose em pacientes com artrite reumatoide em uso de bloqueadores do TNF no Brasil: dados do Registro Brasileiro de Monitoração de Terapias Biológicas BiobadaBrasil
- (2017) Claudia Leiko Yonekura et al. Revista Brasileira De Reumatologia
- The strategic framework of tuberculosis control and prevention in the elderly: a scoping review towards End TB targets
- (2017) Jun Li et al. Infectious Diseases of Poverty
- Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial
- (2017) Morten Ruhwald et al. Lancet Respiratory Medicine
- The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan
- (2017) Chong Hong Lim et al. PLoS One
- Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection
- (2017) Teresa Chiacchio et al. PLoS One
- Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab
- (2017) Chuan-Yu Hsiao et al. PLoS One
- The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis
- (2016) Giovanna Cuomo et al. CLINICAL RHEUMATOLOGY
- Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
- (2016) Elisa Petruccioli et al. EUROPEAN RESPIRATORY JOURNAL
- Risk of developing active tuberculosis in rheumatoid arthritis patients on adalimumab in Japan
- (2016) A. Watanabe et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?
- (2016) Niaz Banaei et al. JOURNAL OF CLINICAL MICROBIOLOGY
- First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus
- (2016) Elisa Petruccioli et al. JOURNAL OF INFECTION
- Predicting tuberculosis risk
- (2016) Sandra V Kik et al. LANCET
- A blood RNA signature for tuberculosis disease risk: a prospective cohort study
- (2016) Daniel E Zak et al. LANCET
- New treatment targets for axial spondyloarthritis: Table 1
- (2016) Joachim Sieper RHEUMATOLOGY
- Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies
- (2016) Sarah Elyoussfi et al. RHEUMATOLOGY INTERNATIONAL
- Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection
- (2016) G. Delogu et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
- (2016) Rein M. G. J. Houben et al. PLOS MEDICINE
- Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis
- (2016) Timothy E Sweeney et al. Lancet Respiratory Medicine
- Tuberculosis
- (2016) Madhukar Pai et al. Nature Reviews Disease Primers
- Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy
- (2016) Der-Yuan Chen et al. PLoS One
- Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study
- (2015) Jean-Pierre Zellweger et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice
- (2015) Fabrizio Cantini et al. AUTOIMMUNITY REVIEWS
- Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data
- (2015) Elena Nikiphorou et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Should all patients undergoing treatment with biologic agents be screened annually for latent tuberculosis infection with an interferon gamma release assay?
- (2015) M. G. Johnson et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Treatment of Latent Tuberculosis Infection
- (2014) Helen R. Stagg et al. ANNALS OF INTERNAL MEDICINE
- Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases
- (2014) Chrisoula Hatzara et al. ANNALS OF THE RHEUMATIC DISEASES
- Combined Use of Mycobacterium tuberculosis–Specific CD4 and CD8 T-Cell Responses Is a Powerful Diagnostic Tool of Active Tuberculosis
- (2014) Virginie Rozot et al. CLINICAL INFECTIOUS DISEASES
- The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature
- (2014) Rossana Scrivo et al. CLINICAL RHEUMATOLOGY
- Risk of tuberculosis among healthcare workers in an intermediate-burden country: A nationwide population study
- (2014) Hsi Chu et al. JOURNAL OF INFECTION
- Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients
- (2014) Teresa Chiacchio et al. JOURNAL OF INFECTION
- Follow-up Testing of Interferon-Gamma Release Assays Are Useful in Ankylosing Spondylitis Patients Receiving Anti-Tumor Necrosis Factor Alpha for Latent Tuberculosis Infection
- (2014) Chang-Nam Son et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
- (2014) Takao Koike et al. Modern Rheumatology
- Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies
- (2014) Alejandro Souto et al. RHEUMATOLOGY
- Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection
- (2013) Dick Menzies et al. ANNALS OF INTERNAL MEDICINE
- Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials
- (2013) V P Bykerk et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)
- (2013) P J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists:in vivoandin vitroanalysis
- (2013) I. Sauzullo et al. BRITISH JOURNAL OF DERMATOLOGY
- Managing tuberculosis in people who use and inject illicit drugs
- (2013) Haileyesus Getahun et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Mycobacterial diseases and antitumour necrosis factor therapy in USA
- (2012) KL Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry
- (2012) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- Contact investigation for tuberculosis: a systematic review and meta-analysis
- (2012) G. J. Fox et al. EUROPEAN RESPIRATORY JOURNAL
- Serial QuantiFERON TB-Gold in-tube testing during LTBI therapy in candidates for TNFi treatment
- (2012) Filippo Bartalesi et al. JOURNAL OF INFECTION
- Mycobacterial Interferon- Release Variations During Longterm Treatment with Tumor Necrosis Factor Blockers: Lack of Correlation with Clinical Outcome
- (2012) R. SCRIVO et al. JOURNAL OF RHEUMATOLOGY
- Silicosis
- (2012) Chi Chiu Leung et al. LANCET
- The effects of rituximab therapy on released interferon- levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection
- (2012) Y.-M. Chen et al. RHEUMATOLOGY
- Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials
- (2012) Elizabeth C. Hsia et al. ARTHRITIS CARE & RESEARCH
- Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders
- (2011) Rachel Smith et al. CURRENT OPINION IN RHEUMATOLOGY
- Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial Load
- (2011) C. L. Day et al. JOURNAL OF IMMUNOLOGY
- Incidence of Tuberculosis Among Korean Patients with Ankylosing Spondylitis Who Are Taking Tumor Necrosis Factor Blockers
- (2011) EUN-MI KIM et al. JOURNAL OF RHEUMATOLOGY
- Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis
- (2011) Molebogeng X Rangaka et al. LANCET INFECTIOUS DISEASES
- Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
- (2011) Timothy R. Sterling et al. NEW ENGLAND JOURNAL OF MEDICINE
- Methylated HBHA Produced in M. smegmatis Discriminates between Active and Non-Active Tuberculosis Disease among RD1-Responders
- (2011) Giovanni Delogu et al. PLoS One
- Risk of Tuberculosis in Dialysis Patients: A Nationwide Cohort Study
- (2011) Claudia C. Dobler et al. PLoS One
- Cardiovascular and other comorbidities in patients with psoriatic arthritis: A comparison with patients with psoriasis
- (2011) Janice A. Husted et al. ARTHRITIS CARE & RESEARCH
- The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
- (2010) I. Solovic et al. EUROPEAN RESPIRATORY JOURNAL
- Human gene expression profiles of susceptibility and resistance in tuberculosis
- (2010) J Maertzdorf et al. GENES AND IMMUNITY
- Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatment
- (2010) Marie-Gaëlle Bray et al. JOINT BONE SPINE
- Treatment of latent tuberculosis infection: An update
- (2010) Philip LOBUE et al. RESPIROLOGY
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada
- (2009) Paul Brassard et al. ARTHRITIS AND RHEUMATISM
- Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry
- (2009) F. Tubach et al. ARTHRITIS AND RHEUMATISM
- New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response
- (2009) Ornella Butera et al. BMC INFECTIOUS DISEASES
- Immunogenicity of Novel DosR Regulon-Encoded Candidate Antigens of Mycobacterium tuberculosis in Three High-Burden Populations in Africa
- (2009) G. F. Black et al. Clinical and Vaccine Immunology
- Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection
- (2009) D. Goletti et al. EUROPEAN RESPIRATORY JOURNAL
- Serious infections during anti-TNFα treatment in rheumatoid arthritis patients
- (2008) Ennio Giulio Favalli et al. AUTOIMMUNITY REVIEWS
- QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases
- (2008) F. Bartalesi et al. EUROPEAN RESPIRATORY JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started